MCTA: SEC Form 6-K filed by Charming Medical Limited
Nasdaq delisting determination for MCTA after SEC trading suspension; trading suspends Nov 9, 2026 unless appealed by Nov 5.
What this filing says
Charming Medical received a Nasdaq letter dated October 29, 2026 saying Nasdaq will delist its shares after an SEC trading suspension tied to suspected social-media manipulation. Unless the company appeals by November 5, 2026, trading is set to be suspended at the opening on November 9, 2026, and the shares could later move to the OTC market without any assurance of an active market. The release states Nasdaq has not found the company did anything wrong, and says the business operations and financial condition are not affected.
Key figures
- Delisting letter date
- October 29, 2026
- SEC trading suspension order
- November 11, 2025
- Appeal deadline
- November 5, 2026
- Expected trading suspension date
- November 9, 2026
- Wellness centers in Hong Kong
- four
Positive for shareholders
- The release states Nasdaq has not communicated any finding of wrongdoing by the company.
- The company says its business operations and financial condition are not affected by the delisting determination.
Negative for shareholders
- Trading in the shares is set to be suspended on November 9, 2026 unless an appeal is requested.
- Nasdaq will file a Form 25-NSE with the SEC to remove the shares from listing and registration.
- Any OTC trading may not develop into an active or sustained market.
Written by Quantisnow AI from this filing. Not financial advice.
Form 6-K main document
Key terms
- Delisting determination:
- A decision by Nasdaq's staff that a company's shares will be removed from the exchange.
- Trading suspension:
- An order that halts trading in a company's securities, here issued by the SEC.
- Form 25-NSE:
- A filing an exchange makes with the SEC to formally remove a security from listing.
- OTC market:
- Over-the-counter trading venues where shares trade outside a major exchange like Nasdaq.
FAQ
When would Charming Medical's shares stop trading on Nasdaq?
The release says trading will be suspended at the opening of business on November 9, 2026, unless the company requests an appeal by November 5, 2026.
Why is Nasdaq delisting Charming Medical?
The release says Nasdaq is acting under its discretionary rule IM-5101-4 after the SEC suspended trading on November 11, 2025 over suspected manipulation through social media recommendations.
Has Charming Medical been found to have done anything wrong?
The release states that Nasdaq has not communicated any findings or determination that the company engaged in wrongdoing.
Keep researching MCTA
- What is Form 6-K?The SEC form foreign private issuers use to furnish material information they publish at home, such as earnings releases and major announcements.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Listed since
- 2025
Follow MCTA and get a push notification the moment its next story breaks.